TY - JOUR
T1 - Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections
AU - Cruz, Melissa R.
AU - Cristy, Shane
AU - Guha, Shantanu
AU - De Cesare, Giuseppe Buda
AU - Evdokimova, Elena
AU - Sanchez, Hiram
AU - Borek, Dominika
AU - Miramón, Pedro
AU - Yano, Junko
AU - Fidel, Paul L.
AU - Savchenko, Alexei
AU - Andes, David R.
AU - Stogios, Peter J.
AU - Lorenz, Michael C.
AU - Garsin, Danielle A.
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Fungal pathogens are a continuing challenge due to few effective antifungals and a rise in resistance. In previous work, we described the inhibition of Candida albicans virulence following exposure to the 68 amino acid bacteriocin, EntV, secreted by Enterococcus faecalis. Here, to optimize EntV as a potential therapeutic and better understand its antifungal features, an X-ray structure is obtained. The structure consists of six alpha helices enclosing a seventh 16 amino acid helix (α7). The individual helices are tested for antifungal activity using in vitro and nematode infection assays. Interestingly, α7 retains antifungal, but not antibacterial activity and is also effective against Candida auris and Cryptococcus neoformans. Further reduction of α7 to 12 amino acids retains full antifungal activity, and excellent efficacy is observed in rodent models of C. albicans oropharyngeal, systemic, and venous catheter infections. Together, these results showcase EntV-derived peptides as promising candidates for antifungal therapeutic development.
AB - Fungal pathogens are a continuing challenge due to few effective antifungals and a rise in resistance. In previous work, we described the inhibition of Candida albicans virulence following exposure to the 68 amino acid bacteriocin, EntV, secreted by Enterococcus faecalis. Here, to optimize EntV as a potential therapeutic and better understand its antifungal features, an X-ray structure is obtained. The structure consists of six alpha helices enclosing a seventh 16 amino acid helix (α7). The individual helices are tested for antifungal activity using in vitro and nematode infection assays. Interestingly, α7 retains antifungal, but not antibacterial activity and is also effective against Candida auris and Cryptococcus neoformans. Further reduction of α7 to 12 amino acids retains full antifungal activity, and excellent efficacy is observed in rodent models of C. albicans oropharyngeal, systemic, and venous catheter infections. Together, these results showcase EntV-derived peptides as promising candidates for antifungal therapeutic development.
UR - http://www.scopus.com/inward/record.url?scp=85139952802&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139952802&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-33613-1
DO - 10.1038/s41467-022-33613-1
M3 - Article
C2 - 36229448
AN - SCOPUS:85139952802
SN - 2041-1723
VL - 13
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 6047
ER -